Global Flow Diversion Aneurysm Treatment Market 2018-2022 to Post a CAGR of 14% | Technavio
LONDON--(BUSINESS WIRE)--Jul 5, 2018--The global flow diversion aneurysm treatment market is expected to post a CAGR of 14% during the period 2018-2022, according to the latest market research report by .
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180705005436/en/
Technavio has published a new market research report on the global flow diversion aneurysm treatment market from 2018-2022. (Graphic: Business Wire)
A key factor that will drive the market is the increasing prevalence of intracranial aneurysms (IAs) and associated risk factors. The risk of IAs increases significantly with age and thus increase in the incidence of IAs is a natural consequence of increased life expectancy. Other risk factors leading to IAs are hypertension, smoking, and excessive alcohol consumption.
This market research report on the provides an analysis of the most important trends expected to impact the market outlook during the forecast period. Technavio classifies an emerging trend as a major factor that has the potential to significantly impact the market and contribute to its growth or decline.
In this report, Technavio highlights the increasing focus on R&D as one of the key emerging trends in the global flow diversion aneurysm treatment market:
Global flow diversion aneurysm treatment market: Increasing focus on R&D
Several major manufacturers and distributors of neuroendovascular treatment devices are significantly investing in R&D to enter the global flow diverters market, owing to the increasing acceptance of flow diversion devices in clinical practice. For instance, in March 2018, Microport Scientific Corporation gained the approval of the CFDA for its in-house developed Tubridge Vascular Reconstruction Device.
“Companies such as Stryker and Medtronic are conducting clinical trials to test the efficacy of their flow diversion devices. Stryker is conducting a clinical trial in the US to determine the safety and effectiveness of Surpass Streamline Flow Diverter in the treatment of large or giant wide-necked IAs in the internal carotid artery up to the terminus. Medtronic is conducting a study to assess the safety and effectiveness of the Artisse Intrasaccular Device in the treatment of bifurcating saccular IAs. Positive results may lead to the increased adoption of these devices,” says a senior analyst at Technavio.
Global flow diversion aneurysm treatment market: Segmentation analysis
This market research report segments the global flow diversion aneurysm treatment market by product (FDS, and intrasaccular flow disruption devices) and geographical regions (APAC, EMEA and the Americas).
The FDS product segment accounted for the largest share of the global flow diversion aneurysm treatment market with 92% share in 2017. The market share of this segment is expected to increase further over the forecast period.
EMEA led the market in 2017 with a market share of 43%, followed the Americas and EMEA respectively. The market share of the three regions will remain stable with small variations over the forecast period.
Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.
Some of the key topics covered in the report include:
Market LandscapeMarket ecosystem Market characteristics Market segmentation analysis
Market SizingMarket sizing Market size and forecast
Five Forces Analysis
Geographical SegmentationRegional comparison Key leading countries
Vendor LandscapeVendors covered Vendor classification Market positioning of vendors Competitive scenario
is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at .
View source version on businesswire.com:https://www.businesswire.com/news/home/20180705005436/en/
CONTACT: Technavio Research
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
INDUSTRY KEYWORD: HEALTH GENERAL HEALTH
SOURCE: Technavio Research
Copyright Business Wire 2018.
PUB: 07/05/2018 12:30 PM/DISC: 07/05/2018 12:31 PM